Stay updated with breaking news from Affinivax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON (dpa-AFX) - GSK plc (GSK.L) on Tuesday said it has completed the acquisition of clinical-stage biopharmaceutical company Affinivax, Inc. The definitive deal was announced by GSK in May this ....
LONDON, May 31 British drugmaker GlaxoSmithKline today snapped up US biopharmaceutical firm Affinivax for up to US$3.3 billion (RM14 billion), expanding further into vaccines. ....
(Getty / E+ / Geber86) After getting off a meaty $120 million round in April, the height of the first wave of COVID-19 infections in the West, Affinivax is a clear indicator that infectious disease and vaccine work is here to stay. Nearly doubling that already impressive B round, the Cambridge, Massachusetts-based biotech has nabbed $226 million, with goals of unseating Pfizer’s Prevnar franchise as well as pushing a set of vaccines for hospital-associated infections into the clinic. Its lead program works as a Prevnar 13 challenger that covers 24 strains of pneumococcus and is fully financed by a partnership with Astellas, as the pair hopes to beat out Pfizer’s big-selling vaccine and its expanded 20-strain effort. ....